This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Privateequity funds have become major players in the professional health care delivery sector in recent years due to acquisitions of professional practices, including physician practices, senior living facilities and the like. Acquisitions of professional practices by privateequity funds involve myriad.
In the pursuit of attractive equity returns, privateequity firms have developed numerous innovative strategies beyond typical leveraged buyouts and take-private transactions. As it happens, this is an industry that has experienced a significant amount of privateequity-backed roll-up activity.
With over 15 years of experience in the technology industry, Kurt has a deep understanding of how technology applies to mergers and acquisitions. rn Summary: rn Kurt Stein discusses the role of technology, specifically artificial intelligence (AI), in mergers and acquisitions. Let's dive in.
CHICAGO, IL - February 6, 2023 – Sun Acquisitions is pleased to announce the successful sale of Trouvaille Med Spa to MedSpa Partners Inc. Through the acquisition of Trouvaille Med Spa, MedSpa Partners Inc. Through the acquisition of Trouvaille Med Spa, MedSpa Partners Inc. About MedSpa Partners Inc.
The platform includes the acquisitions of GEM Manufacturing, Coining MFG, National Manufacturing Co. Targeting sectors with rigorous technical specifications, regulatory compliance standards, and exacting quality requirements, MSK serves customers primarily in the medical, aerospace & defense and telecommunications end markets.
Serving a variety of end markets, including aerospace & defense, electronics and industrials, National offers especially deep experience in the medical end market across various implantable devices, including pacemakers, neuromodulation devices, defibrillators, batteries and capacitors. appeared first on FOCUS.
3 spot on The Deal’s privateequity league table for law firms. Holland & Knight, whose merger with Waller Lansden Dortch & Davis LLP took effect March 1, advised on 108 PE transactions in the first six months of the year, according to data from The Deal. and abroad.
CORE, a privateequity firm focused on manufacturing, industrial technology, and industrial services, previously acquired GEM, a provider of precision deep-drawn metal components and mechanical assemblies, in February 2023. PMP”), a provider of specialty stamping and machining services. FOCUS represented CORE in this transaction.
The New York Times: Mergers, Acquisitions and Dive
JUNE 23, 2024
People have grown more attached to their pets — and more willing to spend money on them — turning animal medicine into a high-tech industry worth billions.
Washington, DC, (September 27, 2024) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture, and corporate finance services, announced today that Dulles Eye Associates has joined ReFocus Eye Health as a supported practice.
They are among the most active advisors to medical professionals in transactions with privateequity-backed organizations. FOCUS managing directors Eric Yetter and Andy Snyder advised Mid-Michigan ENT in this partnership.
Washington, DC, (August 15, 2023) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced today that it has added two new managing directors, Mike McCraw and William R. Bill”) Snow.
On April 23 a group led by privateequity firm TPG agreed to acquire OneOncology, the nation’s largest independent community oncology network, in a deal valued at $2.1 While the biggest recent deal, OneOncology is hardly the first oncology platform to be sold to a privateequity group. US Oncology Network.
Update on PrivateEquity and Insurance Brokerages In our ,, previous article , we reported that the COVID-19 pandemic had not diminished the pace of mergers and acquisitions transactions we are seeing in the insurance agency and brokerage sector. Privateequity firms continue to drive transaction pace and value.
For example, while a pharmaceutical company focused solely on shareholder value might prioritize high-margin drugs for rare conditions, a stakeholder-oriented approach might consider affordability and broader societal health needs , as seen with Gilead's approach to its HIV medications.
They are among the most active advisors to medical professionals in transactions with privateequity-backed organizations. “We Parallel ENT & Allergy is backed by Trinity Hunt Partners , a growth-oriented privateequity firm with deep healthcare experience. “We who serves as Michigan ENT’s managing partner.
Periculum Capital Company, LLC is pleased to announce it has advised Micro-Dyn Medical Systems, Inc., a leading health care software company, in its acquisition by The Brydon Group. based privateequity investor that specializes in acquiring software businesses in partnership with top mid-career executives.
For example, in the biopharma space, AbbVie, Bristol Myers Squibb, AstraZeneca, and Roche each announced multiple big-ticket acquisitions in the fourth quarter – including Abbvie’s acquisition of ImmunoGen for $10.1 billion; Bristol Myer Squibb’s acquisition of RayzeBio for $4.1 billion and Cerevel Therapeutics for $8.7
focuses on the healthcare services, medical device and healthcare IT sectors. .- and Cincinnati-based RC Capital tapped McDermott Will & Emery LLP for legal advice. RC Capital, which has offices in Cincinnati and Raleigh, N.C., In 2022 it was raising its seventh fund with a $300 million target.
In turn, it has led to a surge of mergers and acquisitions in the Government software space, particularly for SaaS businesses. Privateequity firms and larger Government SaaS companies know this as well, and they’re expanding their addressable market by acquiring the expertise they need to dominate in certain spaces.
When you hear the words “healthcare privateequity,” two thoughts probably come to mind: Wait a minute, isn’t healthcare a risky/growth-oriented sector? In most of the world, healthcare is either government-run or a mixed public/private sector. Are there many private healthcare companies for PE firms to acquire?
John Prothrow had a background in mergers and acquisitions and had worked on the buy side of transactions. The brand also receives many medical referrals from podiatrists and other foot specialists. He also acquired a competitor called Happy Feet Plus in Florida, which has been a good acquisition for the brand.
January 9, 2024 2023: A Year of Strategic Consolidation and Diversification In 2023, the Healthcare IT sector witnessed a significant transformation marked by strategic mergers and acquisitions (M&A). Billion): Privateequity firm Thoma Bravo acquired NextGen Healthcare for an enterprise value of $1.8
The year started off with a bang, with mega-deals such as Microsoft’s pending $69 billion acquisition of Activision Blizzard, Elon Musk’s $44 billion acquisition of Twitter and Broadcom’s pending $61 billion acquisition of VMware inked in quick succession. Tech M&A in 2022 was a tale of two halves. trillion. [2]
1] Major all-cash acquisitions have followed, such as Arena Pharmaceutical’s agreement to sell to Pfizer for $6.7 Midsize pharmaceutical buyers pursuing opportunistic acquisition strategies, with robust capital markets and high valuations having limited the pool of attractive assets available in recent years.
billion tie-up between Inmarsat and Viasat was cleared by both regulators, Adobe’s $20 billion proposed acquisition of Figma was abandoned in December 2023 following regulatory pressure. For example, while the $7.3
We organize all of the trending information in your field so you don't have to. Join 38,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content